Crystal Adam

Chief Medical OfficerC4 Therapeutics, Inc. (CCCC) · full profile →Form 4 · filed Jan 5, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$475K
Net Open-Market Flow
-$475K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 4, 2022Option exercise(M)15K$6.49$97K30K
Jan 4, 2022Sell(S)1K$32.66$34K15K
Jan 4, 2022Sell(S)14K$31.59$441K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 4, 2022Option exercise(M)15K$0112K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-001700) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.